Shockwave therapy shows promise for Parkinson's in tiny trial

NCT ID NCT06676995

Completed Symptom relief Sponsor: Spaulding Rehabilitation Hospital Source: ClinicalTrials.gov ↗

First seen Jun 25, 2026 · Last updated Aug 11, 2026 · Updated 3 times

Summary

This small study tested a non-invasive device called Transcranial Pulse Stimulation (TPS) in 14 people with Parkinson's disease. TPS uses sound wave pulses to stimulate the brain. Participants received 12 sessions over four weeks. Researchers checked if TPS safely improved movement, thinking, mood, and other symptoms compared to before treatment.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance: Transcranial Pulse Stimulation (TPS) device
What this could lead to: If it works, this could point toward a non-invasive way to ease movement, thinking, and mood problems in Parkinson's disease.
What could go wrong: This was a very small, early study with only 14 people and no comparison group. Results may not apply to everyone, and the benefits might be small or temporary.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for PARKINSON are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

Parkinson disease

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

PARKINSON

Contacts and locations

Locations

Spaulding Rehabilitation Hospital

Cambridge, Massachusetts, 02138, United States

More trials for these conditions

Other studies related to the condition(s) this trial covers.